Flomox


Combined with:

Loxonin
Mucosta

Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 16.4%
Nasopharyngitis 9.2%
Hypertension 8.4%
Pyrexia 7.1%
Kawasaki's Disease 6.6%
Bronchitis 6.4%
Influenza 6.1%
Infection Prophylaxis 5.7%
Upper Respiratory Tract Inflammation 4.4%
Convulsion 3.8%
Cough 3.4%
Tonsillitis 3.0%
Diabetes Mellitus 2.6%
Gastritis 2.6%
Herpes Zoster 2.6%
Back Pain 2.5%
Benign Prostatic Hyperplasia 2.3%
Otitis Media Acute 2.3%
Pain 2.3%
Upper Respiratory Tract Infection 2.3%
Stevens-johnson Syndrome 10.9%
Interstitial Lung Disease 7.9%
Liver Disorder 7.9%
Hepatic Function Abnormal 6.9%
Pyrexia 6.9%
Rash 5.9%
Rhabdomyolysis 5.9%
Circulatory Collapse 5.0%
Pancytopenia 5.0%
Pyelonephritis Acute 5.0%
Vitamin K Deficiency 5.0%
Drug Eruption 4.0%
Felty's Syndrome 3.0%
Meningitis 3.0%
Pneumonia 3.0%
Renal Failure 3.0%
Respiratory Failure 3.0%
Toxic Epidermal Necrolysis 3.0%
Tubulointerstitial Nephritis 3.0%
Urinary Retention 3.0%
Concomitant
Prophylaxis 16.7%
Hypertension 9.0%
Drug Use For Unknown Indication 7.9%
Rheumatoid Arthritis 5.9%
Product Used For Unknown Indication 5.8%
Upper Respiratory Tract Inflammation 5.7%
Constipation 5.2%
Pyrexia 4.7%
Bronchitis 4.4%
Diabetes Mellitus 4.4%
Asthma 4.0%
Hepatitis C 3.8%
Infection Prophylaxis 3.5%
Nasopharyngitis 3.4%
Osteoporosis 3.1%
Gastritis 2.8%
Pain 2.6%
Cancer Pain 2.5%
Insomnia 2.4%
Premedication 2.3%
Pyrexia 9.1%
Vomiting 8.3%
Interstitial Lung Disease 7.6%
Rash 6.4%
White Blood Cell Count Decreased 6.4%
Femur Fracture 5.7%
Retinal Haemorrhage 5.7%
Platelet Count Decreased 5.3%
Cerebral Infarction 4.9%
Hepatic Function Abnormal 4.9%
White Blood Cell Count Increased 4.9%
Liver Disorder 3.8%
Loss Of Consciousness 3.8%
Pneumonia 3.8%
Rhabdomyolysis 3.8%
Renal Impairment 3.4%
Abnormal Behaviour 3.0%
Death 3.0%
Gamma-glutamyltransferase Increased 3.0%
Malaise 3.0%

Drug Data